1.58  0.095 (6.4%)		06-16 16:00
Open: 1.495 High: 1.62 Volume: 651,043		Pre. Close: 1.485 Low: 1.48 Market Cap: 76(M)

Short term
Mid term
Targets	6-month :	3.1	1-year :	3.97
Resists	First :	2.65	Second :	3.4
Pivot price	2.21
Supports	First :	1.46	Second :	1.21
MAs	MA(5) :	1.57	MA(20) :	2.36
	MA(100) :	2.19	MA(250) :	4.2
MACD	MACD :	-0.3	Signal :	-0.1
%K %D	K(14,3) :	4	D(3) :	4.1
RSI	RSI(14): 37.5
52-week	High :	10.77	Low :	1.39

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CBUS ] has closed above bottom band by 27.2%. Bollinger Bands are 229.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 19 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	1.62 - 1.63	1.63 - 1.64
Low:	1.46 - 1.47	1.47 - 1.48
Close:	1.56 - 1.58	1.58 - 1.6

Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases. The company is based in San Diego, California.

Thu, 12 Jun 2025
Cibus (CBUS) Expands Collaboration with John Innes Centre for Cr - GuruFocus

Thu, 12 Jun 2025
Agricultural Breakthrough: Scientists Find Gene Mutation That Could Transform Farming Economics - Stock Titan

Mon, 09 Jun 2025
Agricultural Biotech Cibus Secures $27.5M Investment to Advance Gene Editing Platform - Stock Titan

Mon, 09 Jun 2025
Cibus, Inc. Announces Closing of $27.5 Million Public Offering - TradingView

Mon, 09 Jun 2025
CBUS ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Cibus, Inc. Shareholders Who Lost Money - ACCESS Newswire

Wed, 04 Jun 2025
Cibus, Inc. Announces Proposed Public Offering | CBUS Stock News - GuruFocus

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares Out	0 (M)
Shares Float	33 (M)
Held by Insiders	2.644e+007 (%)
Held by Institutions	18.1 (%)
Shares Short	2,080 (K)
Shares Short P.Month	0 (K)

EPS	-7.243e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-1 %
Return on Assets (ttm)	994.2 %
Return on Equity (ttm)	-11.4 %
Qtrly Rev. Growth	4.75e+006 %
Gross Profit (p.s.)	47.71
Sales Per Share	-82.44
EBITDA (p.s.)	2.5266e+006
Qtrly Earnings Growth	-11.1 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-56 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.02
Price to Cash Flow	1.38

Dividend	0
Forward Dividend	2.32e+006
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.